ALECENSA Capsule 150mg (アレセンサカプセル150mg) Японія - англійська - すりの適正使用協議会 RAD-AR Council, Japan

alecensa capsule 150mg (アレセンサカプセル150mg)

chugai pharmaceutical co., ltd. - alectinib hydrochloride - white to yellowish white, major axis: approximately 19 mm

Lorviqua Європейський Союз - англійська - EMA (European Medicines Agency)

lorviqua

pfizer europe ma eeig - lorlatinib - carcinoma, non-small-cell lung - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor.lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

LORVIQUA FILM-COATED TABLET 100MG Сінгапур - англійська - HSA (Health Sciences Authority)

lorviqua film-coated tablet 100mg

pfizer private limited - lorlatinib - tablet, film coated - lorlatinib 100 mg

LORVIQUA FILM-COATED TABLET 25MG Сінгапур - англійська - HSA (Health Sciences Authority)

lorviqua film-coated tablet 25mg

pfizer private limited - lorlatinib - tablet, film coated - lorlatinib 25mg

LORBRENA TABLET Канада - англійська - Health Canada

lorbrena tablet

pfizer canada ulc - lorlatinib - tablet - 25mg - lorlatinib 25mg - antineoplastic agents

LORBRENA TABLET Канада - англійська - Health Canada

lorbrena tablet

pfizer canada ulc - lorlatinib - tablet - 100mg - lorlatinib 100mg - antineoplastic agents